Outcome Measures
The primary outcome was the number of psychiatric medications for PSVT patients pre- and 3 months post-ablation. Patients that were prescribed psychiatric medications were followed to examine the difference in number of medications at 3 months post-ablation. Medications evaluated were serotonin selective reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), benzodiazepines (BZDs), anxiolytics, antipsychotics, tricyclic antidepressants, buspirone, trazadone, and bupropion.